Edition:
United States

Neos Therapeutics Inc (NEOS.OQ)

NEOS.OQ on NASDAQ Stock Exchange Global Market

7.15USD
4:00pm EDT
Change (% chg)

$0.05 (+0.70%)
Prev Close
$7.10
Open
$7.00
Day's High
$7.35
Day's Low
$7.00
Volume
52,072
Avg. Vol
68,161
52-wk High
$13.15
52-wk Low
$6.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 10.73 -0.498
FY 2017 Dec '17 7.79 -0.494
Sep '17 6.70 -0.583
Jun '17 4.91 -0.826
Mar '17 5.63 -0.878
FY 2016 Dec '16 3.50 -1.144
Sep '16 1.58 -1.606
Jun '16 1.49 -1.654
Mar '16 2.58 -0.787
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 6 12.10 13.00 11.00 22.80
Quarter Ending Sep-18 6 15.43 16.60 14.40 28.60
Year Ending Dec-18 6 56.79 60.00 53.40 85.32
Year Ending Dec-19 6 111.43 132.00 96.00 153.41
Earnings (per share)
Quarter Ending Jun-18 6 -0.44 -0.42 -0.50 -0.18
Quarter Ending Sep-18 6 -0.36 -0.33 -0.42 -0.06
Year Ending Dec-18 6 -1.56 -1.45 -1.78 -1.51
Year Ending Dec-19 6 -0.26 0.00 -0.67 0.48
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.66 32.90
P/E High - Last 5 Yrs. -- 41.40 47.21
P/E Low - Last 5 Yrs. -- 23.48 24.78
Beta -- 0.80 0.79
Price to Sales (TTM) 6.84 3.42 8.29
Price to Book (MRQ) -- 3.60 4.33
Price to Tangible Book (MRQ) -- 4.46 5.85
Price to Cash Flow (TTM) -- 19.59 21.98
% Owned Institutions 56.80 1.27 2.41

Dividends

  Company industry sector
Dividend Yield -- 1.78 1.65
Dividend Yield - 5 Year Avg -- 0.78 0.80
Dividend 5 Year Growth Rate -- 2.67 4.07
Payout Ratio(TTM) -- 16.62 17.46

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 90.53 3.79 4.91
Sales (TTM) vs TTM 1 Yr. Ago 146.84 10.43 12.76
Sales - 5 Yr. Growth Rate -- 7.39 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 43.27 39.00 35.43
EPS (TTM) vs TTM 1 Yr. Ago 54.54 -- --
EPS - 5 Yr. Growth Rate -- 7.03 8.55
Capital Spending - 5 Yr. Growth Rate -- 8.06 8.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.49 2.55 2.53
Current Ratio (MRQ) 1.82 3.62 3.60
LT Debt to Equity (MRQ) -- 10.57 12.91
Total Debt to Equity (MRQ) -- 13.08 15.97
Interest Coverage (TTM) -9.79 39.94 34.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 56.85 55.35 54.97
Gross Margin - 5 Yr. Avg. -- 52.67 52.78
EBITD Margin (TTM) -170.79 -- --
EBITD - 5 Yr. Avg -- 18.49 15.93
Operating Margin (TTM) -181.20 14.61 0.12
Operating Margin - 5 Yr. Avg. -- 14.23 11.20
Pre-Tax Margin (TTM) -211.13 14.89 2.20
Pre-Tax Margin - 5 Yr. Avg. -- 14.51 11.41
Net Profit Margin (TTM) -211.13 11.29 -1.22
Net Profit Margin - 5 Yr. Avg. -- 10.80 7.70
Effective Tax Rate (TTM) -- 22.50 31.30
Effective Tax Rate - 5 Yr. Avg. -- 23.91 24.62

Efficiency

  Company industry sector
Revenue/Employee (TTM) 218,261 841,727,147 731,572,994
Net Income/Employee (TTM) -460,812 97,990,015 85,104,893
Receivable Turnover (TTM) 1.91 5.60 5.75
Inventory Turnover (TTM) 1.37 2.52 3.58
Asset Turnover (TTM) 0.31 0.88 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -64.77 10.56 10.07
Return on Assets - 5 Yr. Avg. -- 11.70 11.12
Return on Investment (TTM) -97.68 13.20 12.74
Return on Investment - 5 Yr. Avg. -- 15.12 14.40
Return on Equity (TTM) -1,571.92 14.95 14.64
Return on Equity - 5 Yr. Avg. -- 16.37 15.76
  1 Year 3 Year 5 Year
Sales % 173.30 220.77 --
EPS (TTM) % 48.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Neos Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 56.80%
# of Holders: 110
Total Shares Held: 16,469,740
3 Mo. Net Change: 631,683
# New Positions: 9
# Closed Positions: 18
# Increased Positions: 50
# Reduced Positions: 49
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.